T cells, move over. B cells are now reported ... the mannan-binding lectin and alternative pathways of complement activation. The classical and alternative pathways of complement activation ...
is the first and most advanced asset from BeiGene’s chimeric degradation activation compound (CDAC) platform. Oral presentation of the BGB-11417-101 Phase 1 study demonstrated B-cell lymphoma 2 ...